FILE PHOTO: Illustration shows GSK (GlaxoSmithKline) logo FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration Post navigation Previous: GSK bets $2 billion on Bellus cough drug to soothe pipeline fears